
ACADIA PHARMACEUTICALS INC
ACADNASDAQ🏆 #1254 by market capEarnings Nov 4US Equity
$29.76▲ $0.35 (+1.19%)
Live1h▲ 0.1%
24h▲ 1.2%
7d▲ 3.3%
14d▲ 13.0%
30d▲ 16.7%
1y▲ 17.0%
🏦Market Cap
$5.10B
Small Cap
📈Revenue Growth (YoY)
+11.9%
Healthy
📊Gross Margin
91.1%
High
💵FCF Margin
15.3%
Healthy
⚖️P/S Ratio
4.4x
Fair
Otter Score
49
Weak
📊
Analyst Ratings
Price
$29.76
Total
37
Raised
4
Lowered
4
Avg PT
$31.86
H / L
$41 / $15
| Institution | Action | Rating | Date |
|---|---|---|---|
Citizens | Reiterated | Market Outperform | 2026-08-05 |
Oppenheimer | Reiterated | Perform | 2026-08-05 |
RBC Capital | Reiterated | Outperform | 2026-08-05 |
Stifel | Reiterated | Hold | 2026-07-21 |
BMO Capital | Reiterated | Outperform | 2026-07-21 |
B of A Securities | Reiterated | Buy | 2026-06-30 |
Canaccord Genuity | Reiterated | Buy | 2026-06-29 |
Citigroup | Reiterated | Buy | 2026-06-29 |
JP Morgan | Reiterated | Overweight | 2026-03-04 |
TD Cowen | Reiterated | Buy | 2026-02-26 |
Mizuho | Upgraded | Neutral → Outperform | 2026-02-23 |
HC Wainwright & Co. | Reiterated | Buy | 2026-02-03 |
UBS | Reiterated | Buy | 2026-01-06 |
Needham | Reiterated | Buy | 2025-11-06 |
JMP Securities | Reiterated | Market Outperform | 2025-08-07 |
Goldman Sachs | Reiterated | Sell | 2025-08-07 |
Deutsche Bank | Upgraded | Hold → Buy | 2025-05-21 |
Morgan Stanley | Reiterated | Equal Weight | 2025-05-20 |
Baird | Reiterated | Outperform | 2025-05-19 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-02-27 |
Guggenheim | Downgraded | Buy → Neutral | 2025-01-03 |
Loop Capital | Reiterated | Hold | 2022-11-01 |
SVB Leerink | Reiterated | Outperform | 2022-08-09 |
Cowen & Co. | Reiterated | Outperform | 2022-08-08 |
Berenberg | Reiterated | Hold | 2021-06-10 |
Jefferies | Downgraded | Buy → Hold | 2021-04-06 |
Raymond James | Downgraded | Strong Buy → Outperform | 2021-03-09 |
Guggenheim Securities | Reiterated | Buy | 2019-12-16 |
Stifel Nicolaus | Reiterated | Hold | 2019-09-03 |
Leerink Swann | Reiterated | Market Perform → Perform | 2018-11-15 |
Bank of America | Reiterated | Buy | 2018-10-10 |
Piper Sandler | Upgraded | Neutral → Overweight | 2018-09-21 |
PiperJaffray | Upgraded | Neutral → Overweight | 2018-09-21 |
H.C. Wainwright | Reiterated | Buy | 2015-02-24 |
McNicoll Lewis Vlak | Downgraded | Buy → Hold | 2013-08-07 |
Roth Capital | Reiterated | Buy | 2013-04-11 |
Ladenburg Thalmann | Reiterated | Buy | 2012-04-30 |
One row per institution, most recent rating